Literature DB >> 8440743

Molecular mechanism of stomach carcinogenesis.

E Tahara.   

Abstract

Gene changes in multiple oncogenes, multiple growth factors and multiple tumor-suppressor genes are observed in stomach cancer. Among them, those most commonly implicated in both well-differentiated adenocarcinoma and poorly differentiated adenocarcinoma are inactivation (mutations and allele loss) of the p53 gene, and activation (abnormal expression and amplification) of the c-met gene. Moreover, they occur at an early stage of stomach carcinogenesis. In addition, loss of heterozygosity (LOH) on chromosome 5q (APC locus) is frequently associated with well-differentiated adenocarcinoma. LOH on chromosome 18q (DCC locus) and LOH of the bcl-2 gene also are common events of well-differentiated adenocarcinoma. LOH on chromosomes 1q and 7q may be involved in the progression of well-differentiated adenocarcinoma. Conversely, the development of poorly differentiated adenocarcinoma, in addition to changes in p53 and c-met genes, requires reduction or dysfunction of cadherin. Overexpression of bcl-2 protein is observed in poorly differentiated adenocarcinoma or signet-ring cell carcinoma. Moreover, the K-sam gene is amplified preferentially in poorly differentiated adenocarcinoma of scirrhous carcinoma. K-sam amplification in scirrhous carcinoma often occurs independently of c-met gene amplification. LOH on chromosome 1p also is relatively common in poorly differentiated adenocarcinoma. Exceptionally, signet-ring cell carcinoma shares APC mutations. There are some differences in expression of the growth-factor/receptor system between well-differentiated adenocarcinoma and poorly differentiated adenocarcinoma. Moreover, interaction between cell-adhesion molecules in tumor cells expressing c-met and hepatocyte growth factor (HGF) from stromal cells is linked with morphogenesis of two histological types of stomach cancer. Intestinal metaplasia and adenoma of the stomach also contain p53 mutations and K-ras mutations or tpr-met rearrangement. Taken together, different genetic pathways of stomach carcinogenesis may exist for poorly differentiated and well-differentiated stomach cancers. Some of the latter may develop by a cumulative series of gene alterations similar to those of colorectal cancer.

Entities:  

Mesh:

Year:  1993        PMID: 8440743     DOI: 10.1007/bf01212724

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  68 in total

1.  BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.

Authors:  D M Hockenbery; M Zutter; W Hickey; M Nahm; S J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

2.  Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell lines.

Authors:  J H Kim; T Takahashi; I Chiba; J G Park; M J Birrer; J K Roh; H De Lee; J P Kim; J D Minna; A F Gazdar
Journal:  J Natl Cancer Inst       Date:  1991-07-03       Impact factor: 13.506

3.  Molecular cloning of a new transforming gene from a chemically transformed human cell line.

Authors:  C S Cooper; M Park; D G Blair; M A Tainsky; K Huebner; C M Croce; G F Vande Woude
Journal:  Nature       Date:  1984 Sep 6-11       Impact factor: 49.962

4.  Genetic abnormalities and expression of p53 in human colon carcinomas.

Authors:  A Ayhan; W Yasui; H Yokozaki; H Ito; E Tahara
Journal:  Int J Oncol       Date:  1992-09       Impact factor: 5.650

5.  Expression of cripto, a novel gene of the epidermal growth factor gene family, leads to in vitro transformation of a normal mouse mammary epithelial cell line.

Authors:  F Ciardiello; R Dono; N Kim; M G Persico; D S Salomon
Journal:  Cancer Res       Date:  1991-02-01       Impact factor: 12.701

6.  Identification of a chromosome 18q gene that is altered in colorectal cancers.

Authors:  E R Fearon; K R Cho; J M Nigro; S E Kern; J W Simons; J M Ruppert; S R Hamilton; A C Preisinger; G Thomas; K W Kinzler
Journal:  Science       Date:  1990-01-05       Impact factor: 47.728

7.  Growth inhibition of transforming growth factor beta on human gastric carcinoma cells: receptor and postreceptor signaling.

Authors:  M Ito; W Yasui; E Kyo; H Yokozaki; H Nakayama; H Ito; E Tahara
Journal:  Cancer Res       Date:  1992-01-15       Impact factor: 12.701

8.  An alternatively processed mRNA generated from human hepatocyte growth factor gene.

Authors:  K Miyazawa; A Kitamura; D Naka; N Kitamura
Journal:  Eur J Biochem       Date:  1991-04-10

9.  The APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer.

Authors:  A Horii; S Nakatsuru; Y Miyoshi; S Ichii; H Nagase; Y Kato; A Yanagisawa; Y Nakamura
Journal:  Cancer Res       Date:  1992-06-01       Impact factor: 12.701

10.  Reduced levels of transforming growth factor-beta type I receptor in human gastric carcinomas.

Authors:  M Ito; W Yasui; H Nakayama; H Yokozaki; H Ito; E Tahara
Journal:  Jpn J Cancer Res       Date:  1992-01
View more
  75 in total

1.  DNA methylation and carcinogenesis in digestive neoplasms.

Authors:  Javed Yakoob; Xue-Gong Fan; Guo-Ling Hu; Zheng Zhang
Journal:  World J Gastroenterol       Date:  1998-04       Impact factor: 5.742

2.  Bcl-2 expression and allelic loss of the p53 gene in gastric carcinomas.

Authors:  M Saegusa; Y Takano; Y Kamata; J Okayasu
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

3.  P53 Codon 72 polymorphisms: a case-control study of gastric cancer and potential interactions.

Authors:  James Sul; Guo-Pei Yu; Qing-Yi Lu; Ming-Lan Lu; Veronica Wendy Setiawan; Ming-Rong Wang; Chun Hua Guo; Shun-Zhang Yu; Lina Mu; Lin Cai; Robert C Kurtz; Zuo-Feng Zhang
Journal:  Cancer Lett       Date:  2005-08-19       Impact factor: 8.679

4.  Adenocarcinoma of the stomach: a review.

Authors:  James M McLoughlin
Journal:  Proc (Bayl Univ Med Cent)       Date:  2004-10

5.  Immunohistochemical studies on EGF family growth factors in normal and ulcerated human gastric mucosa.

Authors:  S Abe; H Sasano; K Katoh; S Ohara; T Arikawa; T Noguchi; S Asaki; W Yasui; E Tahara; H Nagura; T Toyota
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

6.  Mucin phenotype of gastric cancer and clinicopathology of gastric-type differentiated adenocarcinoma.

Authors:  Tsutomu Namikawa; Kazuhiro Hanazaki
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

7.  Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma.

Authors:  Jae-Hyuk Lee; Susan C Abraham; Hyun-Soo Kim; Jong-Hee Nam; Chan Choi; Min-Cheol Lee; Chang-Soo Park; Sang-Woo Juhng; Asif Rashid; Stanley R Hamilton; Tsung-Teh Wu
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

8.  A p53 genetic polymorphism of gastric cancer: difference between early gastric cancer and advanced gastric cancer.

Authors:  Sun Young Yi; Woon Jung Lee
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

9.  Correlation of p53 over-expression and alteration in p53 gene detected by polymerase chain reaction-single strand conformation polymorphism in adenocarcinoma of gastric cancer patients from India.

Authors:  Sajjad Karim; Arif Ali
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

10.  Gastric carcinogenesis.

Authors:  Ismail Gomceli; Baris Demiriz; Mesut Tez
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.